ReActiv8-B Trial Publication in PAIN
Dr. Chris Gilligan and the team of ReActiv8-B investigators have been pivotal to establishing the emerging field of “Restorative Neurostimulation” for refractory chronic mechanical low back pain. In this publication, the researchers detail the randomized, sham-controlled, double-blinded ReActiv8-B trial to demonstrate safety and efficacy of a novel, implantable restorative-neurostimulator targeting functional instability of the lumbar spine in patients with refractory mechanical chronic low back pain.
Improvements in pain and function from baseline continued to accrue in all outcome measures after conclusion of the double-blind phase, consistent with the restorative nature of the ReActiv8 therapy. Download from PAIN Journal for the full publication.